Information Publication and members pages are updated. 2022-04-01 New PhD students are joining! WISE program is open for PhD candidates! Ensitrelvir (Xocova), a new COVID-19 drug, developed by Shionogi & Co., Ltd. and Hokkaido University approved in Japan